#Bioanalytical Testing Services Market

[global-research-report]

Bioanalytical Testing Services Market Outlook: Key Drivers Shaping the Future of Pharmaceutical and Healthcare Research

The global bioanalytical testing services market size is anticipated to reach USD 7.93 billion by 2030 and is projected to grow at a CAGR of 9.0% from 2024 to 2030, according to a new report by Grand View Research, Inc.An increasing rate of outsourcing R&D activities by several biopharmaceutical companies to streamline their core competencies is one of the major factors supporting the market growth. In addition, the outbreak of COVID-19 has further boosted demand for pharma-analytical testing services as the rapid surge in SARS-CoV-2 infection cases has significantly augmented the production of a larger batch of COVID-19 vaccines across the globe.

Furthermore, the growing demand for pharmaceutical products across the globe has resulted in a surge of pipeline drugs that require bioanalytical testing for development, thus augmenting the market growth. In addition, the market is expected to witness considerable growth over the forecast period owing to an increasing number of contract manufacturing companies expanding their development capacities across the globe. For instance, in September 2023, Cerba HealthCare announced the acquisition of CIRION BioPharma Research, a Canadian contract research laboratory, to expand its bioanalytical capabilities and reduce the time required for implementing intricate clinical trials.

Increasing awareness about product quality, environmental issues, and the safety of consumers are driving companies to outsource tests as a means to ensure that their products comply with the aforementioned aspects. This helps them build brand image and protects as well as enhances reputation. The U.S. FDA has conducted workshops to increase awareness regarding bioanalytical testing and related regulations.

Key operating companies are undertaking various strategic initiatives to strengthen their market presence. For instance, in August 2023, Pace Analytical Services announced the acquisition of Alpha Analytical, adding new capabilities such as advanced hydrocarbon analytical support along with expanded sediment & tissue testing. Moreover, in April 2022, Charles River Laboratories acquired Explora BioLabs, a prominent player in contract research services, for USD 295 million in cash. This has broadened the company’s operating capabilities in the market.

Bioanalytical Testing Services Market Report Highlights

Small molecule segment accounted for the largest revenue share of over 55.6% in 2023. The high demand for generic drug development boosts the segment growth

Large moleculesegment is anticipated to witness a significant CAGR of 9.61% during the forecast period. This is attributed to the increased investment and focus on the development of biopharmaceuticals

The bioequivalence segment is estimated to witness the fastest CAGR during the forecast period. This is attributed to the growing production and consumption of generics & biosimilars

The sample preparation segment held a significant market share in 2023 and is estimated to expand further at the fastest CAGR from 2024 to 2030

North America was the largest regional market in 2023 due to the strong presence of several pharmaceutical players in the U.S.

On the other hand, the market in Asia Pacific is projected to register the fastest CAGR from 2024 to 2030 owing to increasing pharmaceutical & biotechnology activities, rising healthcare expenditure

Bioanalytical Testing Services Market Segmentation

Grand View Research has segmented the global bioanalytical testing services market based on molecule, test, workflow, and region:

Bioanalytical Testing Services Molecule Outlook (Revenue, USD Billion, 2018 - 2030)

Small Molecule

Large Molecule

LC-MS Studies

Immunoassays

PK

ADA

Others

Others

Bioanalytical Testing Services Test Outlook (Revenue, USD Billion, 2018 - 2030)

ADME

In-Vivo

In-Vitro

PK

PD

Bioavailability

Bioequivalence

Others

Bioanalytical Testing Services Workflow Outlook (Revenue, USD Billion, 2018 - 2030)

Sample Preparation

Protein Precipitation

Liquid-Liquid Extraction

Solid Phase Extraction

Sample Analysis

Hyphenated technique

Chromatographic technique

Electrophoresis

Ligand Binding Assay

Mass Spectrometry

Nuclear Magnetic Resonance

Other Workflow Processes

Bioanalytical Testing Services Application Outlook (Revenue, USD Billion, 2018 - 2030)

Oncology

Neurology

Infectious Diseases

Gastroenterology

Cardiology

Other Applications

Bioanalytical Testing Services End Use Outlook (Revenue, USD Billion, 2018 - 2030)

Pharma & BioPharma Companies

CDMO

CRO

Bioanalytical Testing Services Regional Outlook (Revenue, USD Billion, 2018- 2030)

North America

US

Canada

Europe

UK

Germany

France

Italy

Spain

Denmark

Sweden

Norway

Netherlands

Switzerland

Asia Pacific

India

China

Japan

South Korea

Australia

Thailand

Indonesia

Malaysia

Singapore

Taiwan

Latin America

Brazil

Mexico

Argentina

Colombia

Middle East and Africa (MEA)

South Africa

Saudi Arabia

UAE

Kuwait

Israel

List of Key Players

ICON Plc

Thermo Fisher Scientific Inc (PPD, Inc.)

Charles River Laboratories International

Covance, Inc.

IQVIA

Syneos Health

SGS SA

Labcorp (Toxikon)

Intertek Group Plc

Pace Analytical Services LLC

Order a free sample PDF of the Bioanalytical Testing Services Market Intelligence Study, published by Grand View Research.

[businesspointnews]

Bioanalytical Testing Services Market Share, Demand, Trends and Forecast 2023-2028 | Healthcare Industry

IMARC Group has recently released a new research study titled “Bioanalytical Testing Services Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028”, offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends and competitive landscape to understand the current and future market scenarios. How big is the bioanalytical testing…

[neha24blog]

Bioanalytical Testing Services Market Segmented On The Basis Of Product, Application, Region And Forecast 2030: Grand View Research Inc.

San Francisco, 28 Nov 2023: The Report Bioanalytical Testing Services Market Size, Share & Trends Analysis Report By Molecule (Small, Large), By Test (Bioavailability, Bioequivalance), By Workflow (Sample Analysis, Sample Preparation), And Segment Forecasts, 2023 – 2030 The global bioanalytical testing services market size is expected to reach USD 7,645.7 million by 2030, according to a new…

[marketreports-blog]

According to latest Report, The U.S. bioanalytical testing services market size was USD 1.25 billion in 2023, calculated at USD 1.37 billion in 2024 and is expected to reach around USD 3.07 billion by 2033, expanding at a CAGR of 9.4 % from 2024 to 2033.

[healthcare-domain]

According to the new market research report "Bioanalytical Testing Services Market by Type, Application (Oncology, Neurology, Infectious Diseases, Gastroenterology, Cardiology), End User and Region (North America, Europe, APAC, Latin America, MEA) - Global Forecast to 2027", The global bioanalytical testing services market is projected to reach USD 6.0 billion by 2027 from an estimated USD 2.9 billion in 2022, at a CAGR of 15.6% during the forecast period.

[businesspointnews]

Bioanalytical Testing Services Market Size, Share, Demand, Growth and Forecast 2023-2028

IMARC Group has recently released a new research study titled “Bioanalytical Testing Services Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028”, offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends and competitive landscape to understand the current and future market scenarios. How big is the bioanalytical testing…

[clinfinite001]

 Clinical Research Companies in Hyderabad: A Hub of Innovation

Introduction

Hyderabad has become one of the leading cities in India for clinical research, with a growing number of organizations offering services that support the development of new medicines, treatments, and healthcare innovations. The city’s emerging clinical research landscape has positioned it as an attractive destination for both national and international pharmaceutical and biotechnology companies looking to conduct clinical trials, preclinical studies, and drug development.

The Growing Clinical Research Landscape in Hyderabad

Over the past decade, Hyderabad has attracted global attention as a major hub for clinical research, driven by factors such as a skilled workforce, cost efficiency, and regulatory advancements. With its rich infrastructure, robust educational institutions, and proximity to top healthcare providers, the city has become a focal point for pharmaceutical companies seeking to accelerate the development of new treatments and therapies. This growth has been supported by favorable government policies and investments, which continue to drive the sector’s expansion.

Top Clinical Research Companies in Hyderabad

Syngene International

Syngene International is a leading Contract Research Organization (CRO) that offers integrated services to the pharmaceutical, biotechnology, and healthcare sectors. With a comprehensive suite of services including drug discovery, development, and manufacturing support, Syngene is at the forefront of clinical research in Hyderabad. The company works with global clients to streamline the drug development process, making it one of the city’s top CROs.

IQVIA

IQVIA provides innovative healthcare solutions and conducts clinical trials to ensure the safety and efficacy of new therapies. The company offers a range of services including clinical development, market access, and patient safety monitoring. With a strong presence in Hyderabad, IQVIA contributes significantly to India’s growing role in global clinical trials and healthcare data analytics.

GVK BIO

GVK BIO offers comprehensive drug discovery and development services and is a key player in India’s growing CRO sector. With its state-of-the-art facilities and expertise in areas like bioanalytical testing, clinical pharmacology, and toxicology, GVK BIO plays a crucial role in supporting pharmaceutical and biotech companies in the development of novel therapies.

Medpace

Medpace is a global, full-service clinical contract research organization that offers clinical trial services in Hyderabad for clinical and regulatory support. Medpace focuses on providing high-quality clinical trials and regulatory services to ensure that new therapies meet global standards. The company’s ability to navigate complex regulatory landscapes and support international studies has made it an important player in the field.

Factors Contributing to the Growth of Clinical Research in Hyderabad

Hyderabad’s rapid growth as a clinical research hub is due to several factors, including its highly educated workforce, large patient pool, and favorable business environment. The city is home to a large number of medical schools, research institutes, and training programs, producing a steady supply of highly qualified clinical research professionals. Additionally, the city’s large, diverse population provides an ideal environment for patient recruitment, which is critical for the success of clinical trials. Supportive government policies, such as tax incentives and investment in healthcare infrastructure, also contribute to Hyderabad’s growth as a clinical research destination.

Challenges in Clinical Research in Hyderabad

While Hyderabad’s clinical research industry is booming, there are challenges such as regulatory hurdles, recruitment difficulties, and maintaining the quality of clinical trials. India’s complex regulatory environment, while improving, can still be difficult to navigate, which sometimes leads to delays in trial approval or regulatory compliance. Additionally, recruiting patients for clinical trials can be time-consuming, and maintaining consistent trial quality across a large population can prove challenging.

Future Outlook for Clinical Research in Hyderabad

With technological advancements, partnerships with international organizations, and a strong focus on personalized medicine, the future of clinical research in Hyderabad looks promising. The city is increasingly adopting digital technologies such as electronic data capture (EDC), artificial intelligence (AI), and telemedicine to improve the efficiency and accuracy of clinical trials. Furthermore, Hyderabad’s collaboration with global pharmaceutical companies and research institutes positions it well for continued growth in clinical research. Personalized medicine, with a focus on genetic-based treatments, is also expected to drive innovation and shape the future of clinical trials.

Conclusion

Hyderabad continues to solidify its position as a global leader in clinical research, playing a crucial role in advancing medical science and improving global healthcare outcomes. The city’s dynamic CRO landscape, combined with its skilled workforce, strong infrastructure, and favorable regulatory environment, makes it an attractive destination for pharmaceutical and biotech companies looking to develop and test new therapies. As the industry evolves and technology continues to improve, Hyderabad will remain at the forefront of clinical research and innovation.

[clinfinitesolution1]

The Role of CRO Companies in Hyderabad’s Pharma Boom

Introduction: The Growing Landscape of CRO Companies in Hyderabad

Hyderabad has emerged as a major hub for Contract Research Organizations (CROs), playing a pivotal role in the global pharmaceutical and biotechnology industries. With its strong infrastructure, skilled workforce, and presence of leading pharma giants, the city has become a preferred destination for clinical research and drug development. The rapid growth of CRO companies in Hyderabad is contributing significantly to the global healthcare sector by accelerating the development of new drugs and medical treatments.

What Are CRO Companies and Their Role in Drug Development?

CRO companies provide essential services in clinical trials, regulatory affairs, and drug development, helping pharmaceutical companies bring innovative medicines to market faster. These organizations support pharmaceutical, biotechnology, and medical device companies in conducting research by offering expertise in clinical trial management, data analytics, pharmacovigilance, and regulatory submissions. Their involvement ensures the smooth execution of drug discovery and approval processes while maintaining compliance with international regulatory standards.

Why Hyderabad Is a Preferred Destination for CRO Companies

Hyderabad has become a hotspot for CRO companies due to its world-class infrastructure, thriving pharmaceutical ecosystem, and highly skilled talent pool. The city is home to prestigious research institutions and biotech parks that foster innovation in drug development. Additionally, Hyderabad offers a cost-effective environment for conducting clinical trials, making it an attractive destination for global pharma companies seeking high-quality research solutions. The presence of regulatory bodies and government support further strengthens the city's position as a leader in the CRO industry.

Top CRO Companies in Hyderabad

Several reputed CRO companies in Hyderabad offer end-to-end research services, catering to global pharmaceutical and biotech firms. Some of the leading CROs in the city include:

Syngene International – A premier contract research and manufacturing services provider.

Parexel International – A global CRO with a strong presence in Hyderabad, offering clinical trial and regulatory services.

Siro Clinpharm – Specializing in clinical trial management, biostatistics, and data analytics.

GVK Biosciences – A key player in drug discovery and development, supporting global pharmaceutical firms.

Vimta Labs – Known for its expertise in preclinical and clinical research solutions.

Key Services Offered by CRO Companies in Hyderabad

CROs in Hyderabad provide a wide range of research and development services, helping pharmaceutical companies accelerate drug discovery and clinical trials. Some of the core services offered include:

Clinical Trials (Phase I-IV): Conducting human trials to evaluate the safety and efficacy of new drugs.

Bioanalytical and Preclinical Research: Testing drug compounds before they enter clinical trials.

Regulatory Affairs and Compliance: Ensuring adherence to regulatory guidelines for drug approval.

Data Management and Biostatistics: Analyzing clinical data for informed decision-making.

Pharmacovigilance and Drug Safety: Monitoring and managing adverse drug reactions.

The Impact of CRO Companies on Hyderabad’s Pharma Industry

The presence of top CRO companies has significantly contributed to Hyderabad’s reputation as India’s "Pharma and Biotech Capital." These organizations play a crucial role in strengthening the city’s pharmaceutical sector by facilitating innovative research and development. As a result, Hyderabad has become a key player in the global healthcare industry, attracting investments from multinational pharmaceutical companies.

Future Trends in the CRO Industry in Hyderabad

With advancements in AI-driven research, decentralized clinical trials, and personalized medicine, Hyderabad’s CRO industry is poised for significant growth. The integration of cutting-edge technology in clinical research is expected to enhance efficiency, reduce costs, and improve patient outcomes. Additionally, the growing focus on biosimilars and biologics is likely to further boost the demand for CRO services in Hyderabad.

How to Choose the Right CRO Company in Hyderabad

Selecting the right CRO company depends on several factors, including expertise, regulatory compliance, technological capabilities, and global reach. Pharmaceutical companies should evaluate a CRO’s track record, service offerings, and industry reputation before partnering with them. A well-established CRO with a proven history of successful clinical trials can ensure high-quality research outcomes and regulatory approvals.

Conclusion: Hyderabad – A Thriving Hub for CRO Excellence

With its robust ecosystem, top-tier research facilities, and skilled workforce, Hyderabad continues to be a preferred destination for CRO companies, driving innovation in drug development. As the demand for clinical research and regulatory services continues to grow, the city is set to play an even greater role in shaping the future of the pharmaceutical and biotechnology industries.